Research, involving scientists and doctors at the University of Southampton and Royal Bournemouth Hospital, has identified a network of genes that are likely to be shared by all patients who have ...
In the past 25 years — from 2000 to 2024 — we have witnessed a revolution in the management, treatment, and outcome of what used to be the most lethal hematologic cancer: Philadelphia ...
Jaypirca is a targeted therapy for CLL and other specific cancers. It is known as a Bruton’s tyrosine kinase inhibitor (BTK inhibitor). BTK is an enzyme that helps certain types of cancer cells grow.
Leukemia, a cancer of the body’s blood-forming tissues including bone marrow and lymphatic system, affects approximately 60,530 Americans each year according to the American Cancer Society. While ...
In "Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how clinicians can communicate effectively and ...
Effects of the COVID-19 pandemic on staging and treatment patterns in non-small cell lung cancer: A large national study. New and worsening HTN during 12-month follow-up period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results